Axcelis Technologies, Inc.

Fundamentals7.5
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Strong Liquidity
  • Margin Compression
  • Cash Conversion

AI
AI Summary

6.0

ACLS is no longer a pure semiconductor momentum trade but a cash-rich special situation: despite a strong balance sheet and solid profitability, the sharp Q1 revenue/margin reset means upside now depends on both a cyclical recovery and clean Veeco merger execution, so the stock is only compelling if operating trends stabilize soon.

ExecutionRisk
CashFlow
M&A‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.5

Key Financial Insights:

  • Strong Liquidity
  • Margin Compression
  • Cash Conversion

ACLS remains financially strong with solid profitability, low leverage, and robust cash generation, but the latest quarter showed notable margin compression and the stock is not cheap on trailing results.

StrongBalanceSheet
MarginPressure

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Breakout surge
  • Momentum cooled
  • Support intact

ACLS stayed in an uptrend over the last month after breaking above $139–$143 and rallying to $171, but the pullback to $155.18 and repeated rejection near $161–$165 show fading momentum, making the breakout zone the key support to watch.

bullish
watch
Support Level: $139–$143
Resistance Level: $161–$165

Sharp extension to $171 on 2026-05-06, followed by a choppy pullback from the highs

Sentiment & News

6.0

Key News Insights:

  • Merger catalyst
  • EPS beat
  • Integration risk

Axcelis gained momentum on a proposed $4.4 billion all-stock merger with Veeco and a slight Q1 EPS beat, but investors are still weighing integration and China approval risks.

earnings
merger

The news is modestly supportive for ACLS as merger upside and a small earnings beat are tempered by deal-execution and regulatory uncertainty